-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
This article is reproduced from the WeChat public account of " China Biotechnology Network" .
This article is reproduced from " This article is reproduced from " This article is reproduced from the WeChat public account of " China Biotechnology Network" China Biotechnology Network " China Biotechnology Network" .WeChat public account .
According to the World Health Organization, depression has become the fourth largest disease in the world, affecting more than 350 million people worldwide, and this group is still growing rapidly
According to an epidemiological survey in China, the lifetime prevalence of depression in China is 6.
8% .
According to the "China National Mental Health Development Report (2019-2020)", young people aged 18 to 34 are the most anxious group among adults .
In 2020, the detection rate of depression among adolescents in China was 24.
6, of which severe depression was 7.
4% .
According to an epidemiological survey in China, the lifetime prevalence of depression in China is 6.
8% .
According to the "China National Mental Health Development Report (2019-2020)", young people aged 18 to 34 are the most anxious group among adults .
In 2020, the detection rate of depression among adolescents in China was 24.
As a result, a large number of people are taking prescription antidepressants every day
Antidepressants were introduced in the 1950s.
Although new drugs have been developed in an endless stream in recent years, they are still dominated by selective serotonin reuptake inhibitors (SSRIs)
However, drugs have side effects.
A new review published in the Drug and Therapeutics Bulletin Drug and Therapeutics Bulletin Drug and Therapeutics Bulletin , a subsidiary of the British Medical Journal, raises concerns about current antidepressant prescriptions
In recent years, there has been controversy over the role of antidepressants in treatment and the associated harms when they are discontinued
.
Moreover, there is considerable uncertainty regarding the benefits of short- and long-term antidepressant use, especially the lack of significant clinical differences between antidepressant and placebo treatments
In recent years, there has been controversy over the role of antidepressants in treatment and the associated harms when they are discontinued
End
References:
References:[1] https://dtb.
[1] https://dtb.
[2] https://doi.
org/10.
1016/S0140-6736(21)02143-7 Leave a message here